EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 50 / No 3 (September 2018) J Extra Corpor Technol, 50 3 (2018) 193-198 References
Free Access
Issue
J Extra Corpor Technol
Volume 50, Number 3, September 2018
Page(s) 193 - 198
DOI https://doi.org/10.1051/ject/201850193
Published online 15 September 2018
  1. Hajjar RJ Potential of gene therapy as a treatment for heart failure. J Clin Invest. 2013;123:53–61. [CrossRef] [PubMed] [Google Scholar]
  2. Katz MG, Fargnoli AS, Kendle AP, et al. Gene therapy in cardiac surgery: Clinical trials, challenges, and perspectives. Ann Thorac Surg. 2016;101:2407–16. [CrossRef] [PubMed] [Google Scholar]
  3. Katz MG, Swain JD, White JD, et al. Cardiac gene therapy: Optimization of gene delivery techniques in vivo. Hum Gene Ther. 2010;21:371–80. [CrossRef] [PubMed] [Google Scholar]
  4. Donahue JK, Kikkawa K, Johns DC, et al. Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci U S A 1997;94:4664–8. [CrossRef] [PubMed] [Google Scholar]
  5. Davidson MJ, Jones JM, Emani SM, et al. Cardiac gene delivery with cardiopulmonary bypass. Circulation. 2001;104:131–3. [CrossRef] [PubMed] [Google Scholar]
  6. Jones JM, Wilson KH, Koch WJ, et al. Adenoviral gene transfer to the heart during cardiopulmonary bypass: Effect of myocardial protection technique on transgene expression. Eur J Cardiothorac Surg. 2002;21:847–52. [CrossRef] [PubMed] [Google Scholar]
  7. Katz MG, Brandon-Warner E, Fargnoli AS, et al. Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression. J Thorac Cardiovasc Surg. 2016;151:1191–200. [CrossRef] [PubMed] [Google Scholar]
  8. Bridges CR, Burkman JM, Malekan R, et al. Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation. Ann Thorac Surg. 2002;73:1939–46. [CrossRef] [PubMed] [Google Scholar]
  9. Bridges CR ‘Recirculating cardiac delivery’ method of gene delivery should be called ‘non-recirculating’ method. Gene Ther. 2009;16:939–40. [CrossRef] [PubMed] [Google Scholar]
  10. Katz MG, Fargnoli AS, Williams RD, et al. Safety and efficacy of high-dose AAV 9 encoding SERCA2a delivered by molecular cardiac surgery with recirculating delivery in ovine ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2014;148:1065–72. [CrossRef] [PubMed] [Google Scholar]
  11. Giordano FJ Retrograde coronary perfusion: A superior route to deliver therapeutics to the heart? J Am Coll Cardiol. 2003;42:1129–31. [CrossRef] [PubMed] [Google Scholar]
  12. Hinkel R, Trenkwalder T, Kupatt C Gene therapy for ischemic heart disease. Expert Opin Biol Ther. 2011;11:723–37. [CrossRef] [PubMed] [Google Scholar]
  13. Boekstegers P, Kupatt C Current concepts and application of coronary venous retroinfusion. Basic Res Cardiol. 2004;99:373–81. [CrossRef] [PubMed] [Google Scholar]
  14. Katz MG, Fargnoli AS, Pritchette LA, et al. Gene delivery technologies for cardiac applications. Gene Ther. 2012;19:659–69. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.